Remogliflozin Etabonate + Vildagliptin is used to improve blood sugar control in adults with type 2 diabetes mellitus.
This combination is commonly used for:
• Type 2 diabetes mellitus: Helps lower high blood sugar levels when diet, exercise, and a single medicine are not enough to control blood sugar.
• Blood sugar control alongside other antidiabetic medicines: Used together with other treatments, such as metformin, when advised by a doctor, to achieve better blood sugar control.
Upper respiratory tract infections
Nasopharyngitis
Headache
Urinary tract infections
Genital fungal infections
Remogliflozin Etabonate + Vildagliptin works through two complementary mechanisms to lower blood sugar levels.
Remogliflozin Etabonate is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It blocks the reabsorption of glucose in the kidneys, causing excess glucose to be removed from the body through urine instead of returning to the bloodstream.
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It blocks the DPP-4 enzyme, which normally breaks down hormones that trigger insulin release. This extends the action of these hormones, increasing insulin release when blood sugar is high and reducing excess glucose production by the liver.
Together, the two medicines lower blood sugar by reducing glucose absorption, increasing its removal through urine, and improving the body's own insulin response.

Doctor of Medicine

Bachelor of Dental Surgery
Remogliflozin Etabonate + Vildagliptin can be taken orally (tablets).
This medicine is meant for adults only of age above 18 years.
This medicine is contraindicated in patients with hypersensitivity to any component of the medication.
It is not recommended for treatment of type 1 diabetes or diabetic ketoacidosis.
Remogliflozin Etabonate + Vildagliptin may interact with digoxin (like lanoxin) and medicines metabolized by CYP3A4 (such as simvastatin).
If you miss a dose of Remogliflozin Etabonate + Vildagliptin, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses together to make up for a missed one.
Most side effects are temporary and generally harmless and resolve when discontinuing this medicine. However, if you experience any severe side effects or worsening of any symptoms, please consult your doctor.
For common side effects like nasopharyngitis, ensure to rest and stay hydrated.
For headaches, try a cool compress on your forehead or at the back of your neck.
This medication does not generally affect your ability to drive or operate heavy machinery. However, if you experience dizziness or drowsiness after taking this medication, avoid driving or operating machines.
Always consult your doctor before using this medicine if you're pregnant or breastfeeding.
Patients with severe renal impairment should avoid using this medication.
Caution should also be taken by patients at risk for volume depletion, hypotension and electrolyte imbalances.
Maintain a healthy diet. Focus on foods lower in fat and calories, especially if you're overweight.
Include physical activity in your daily routine. Aim for 30 minutes of moderate physical activity most days of the week.
Regularly monitor blood sugar levels to ensure the medication is working effectively.
Regular check-ups with your doctor to keep track of your progress and adjust the medication if necessary.
Frequently asked questions
Since the active ingredients in Remogliflozin Etabonate + Vildagliptin are purely chemical substances, they should be suitable for vegan consumption. However, you should consult a doctor or pharmacist about the inactive ingredients and excipients present in the tablet, as some of these might be sourced from non-vegan origins.
The half-life of remogliflozin etabonate is approximately 2-3 hours and that of vildagliptin is 2-4 hours. This suggests that most of the medicine would be cleared from your system within a day. However, this can vary depending on individual factors such as your metabolism, age, health status, and other medicines you are taking.
Remogliflozin Etabonate + Vildagliptin is not directly associated with affecting mood. However, maintaining a stable blood sugar level can contribute to overall mood stability. If you experience any significant changes in your mood after starting this medication, please consult your doctor.
Remogliflozin Etabonate + Vildagliptin is not typically associated with weight gain. In fact, some patients may experience weight loss due to the enhanced glucose excretion in urine caused by remogliflozin etabonate.
While there's no direct natural alternative to this medicine, a balanced diet and regular exercise play a critical role in managing type 2 diabetes. Foods rich in fibre and low in saturated fat can help control blood glucose levels. However, these should not replace your prescribed medication but rather complement it.
Remogliflozin Etabonate + Vildagliptin is not associated with affecting menstrual cycle. If you notice any irregularities, consult your doctor.
Remogliflozin Etabonate + Vildagliptin does not cause dependency or withdrawal symptoms. It is a prescription medication used for managing type 2 diabetes.





Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorAdvertise with UsSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.28.10
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

